360 related articles for article (PubMed ID: 31090655)
21. CD4(+)and CD8(+)T-cell reactions against leukemia-associated- or minor-histocompatibility-antigens in AML-patients after allogeneic SCT.
Steger B; Milosevic S; Doessinger G; Reuther S; Liepert A; Braeu M; Schick J; Vogt V; Schuster F; Kroell T; Busch DH; Borkhardt A; Kolb HJ; Tischer J; Buhmann R; Schmetzer H
Immunobiology; 2014 Apr; 219(4):247-60. PubMed ID: 24315637
[TBL] [Abstract][Full Text] [Related]
22. Quality of T-cells after stimulation with leukemia-derived dendritic cells (DC) from patients with acute myeloid leukemia (AML) or myeloid dysplastic syndrome (MDS) is predictive for their leukemia cytotoxic potential.
Liepert A; Grabrucker C; Kremser A; Dreyssig J; Ansprenger C; Freudenreich M; Kroell T; Reibke R; Tischer J; Schweiger C; Schmid C; Kolb HJ; Schmetzer H
Cell Immunol; 2010; 265(1):23-30. PubMed ID: 20663492
[TBL] [Abstract][Full Text] [Related]
23. The efficient generation of immunocompetent dendritic cells from leukemic blasts in acute myeloid leukemia: a local experience.
Bagheri K; Alimoghadam K; Pourfathollah AA; Hassan ZM; Hajati J; Moazzeni SM
Pathol Oncol Res; 2009 Jun; 15(2):257-67. PubMed ID: 18807213
[TBL] [Abstract][Full Text] [Related]
24. In vitro induction of a dendritic cell phenotype in primary human acute myelogenous leukemia (AML) blasts alters the chemokine release profile and increases the levels of T cell chemotactic CCL17 and CCL22.
Olsnes AM; Ryningen A; Ersvaer E; Bruserud Ø
J Interferon Cytokine Res; 2008 May; 28(5):297-310. PubMed ID: 18547160
[TBL] [Abstract][Full Text] [Related]
25. Leukaemia-derived dendritic cells can be generated from blood or bone marrow cells from patients with myelodysplasia: a methodological approach under serum-free culture conditions.
Kufner S; Zitzelsberger H; Kroell T; Pelka-Fleischer R; Salem A; de Valle F; Schmid C; Schweiger C; Kolb HJ; Schmetzer HM
Scand J Immunol; 2005 Jul; 62(1):75-85. PubMed ID: 16091127
[TBL] [Abstract][Full Text] [Related]
26. Clonal heterogeneity of dendritic cells derived from patients with chronic myeloid leukemia and enhancement of their T-cells stimulatory activity by IFN-alpha.
Wang C; Al-Omar HM; Radvanyi L; Banerjee A; Bouman D; Squire J; Messner HA
Exp Hematol; 1999 Jul; 27(7):1176-84. PubMed ID: 10390193
[TBL] [Abstract][Full Text] [Related]
27. In vitro-induced response patterns of antileukemic T cells: characterization by spectratyping and immunophenotyping.
Reuther S; Schmetzer H; Schuster FR; Krell P; Grabrucker C; Liepert A; Kroell T; Kolb HJ; Borkhardt A; Buhmann R
Clin Exp Med; 2013 Feb; 13(1):29-48. PubMed ID: 22441559
[TBL] [Abstract][Full Text] [Related]
28. Combined immunophenotyping and fluorescence in situ hybridization with chromosome-specific DNA probes allows quantification and differentiation of ex vivo generated dendritic cells, leukemia-derived dendritic cells and clonal leukemic cells in patients with acute myeloid leukemia.
Kremser A; Kufner S; Konhaeuser E; Kroell T; Hausmann A; Tischer J; Kolb HJ; Zitzelsberger H; Schmetzer H
Leuk Lymphoma; 2013 Jun; 54(6):1297-308. PubMed ID: 23163701
[TBL] [Abstract][Full Text] [Related]
29. Various 'dendritic cell antigens' are already expressed on uncultured blasts in acute myeloid leukemia and myelodysplastic syndromes.
Dreyssig J; Kremser A; Liepert A; Grabrucker C; Freudenreich M; Schmid C; Kroell T; Scholl N; Tischer J; Kufner S; Salih H; Kolb HJ; Schmetzer HM
Immunotherapy; 2011 Sep; 3(9):1113-24. PubMed ID: 21913833
[TBL] [Abstract][Full Text] [Related]
30. CTLA-4 blockade by a human MAb enhances the capacity of AML-derived DC to induce T-cell responses against AML cells in an autologous culture system.
Zhong RK; Loken M; Lane TA; Ball ED
Cytotherapy; 2006; 8(1):3-12. PubMed ID: 16627340
[TBL] [Abstract][Full Text] [Related]
31. Effects of gamma-irradiation on acute myelogenous leukemia blasts: in vitro studies of proliferation, constitutive cytokine secretion, and accessory cell function during T cell activation.
Bruserud O; Ulvestad E
J Hematother Stem Cell Res; 1999 Aug; 8(4):431-41. PubMed ID: 10634181
[TBL] [Abstract][Full Text] [Related]
32. Generation of T-cell lines to autologous acute myeloid leukemia cells by competitive limiting dilution culture of acute myeloid leukemia mononuclear cells.
Zhong RK; Lane TA; Ball ED
Exp Hematol; 2008 Apr; 36(4):486-94. PubMed ID: 18249062
[TBL] [Abstract][Full Text] [Related]
33. [Study on induction of dendritic cells from myeloid leukemia cell lines and their antitumor immune function].
Luo YP; Li YG; Cai DC; Ren H
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2002 Jun; 10(3):229-35. PubMed ID: 12513792
[TBL] [Abstract][Full Text] [Related]
34. Effects of interferon-alpha (IFN) on the expression of interleukin 1-beta (IL-1), interleukin 6 (IL-6), granulocyte-macrophage colony-stimulating factor (GM-CSF) and tumor necrosis factor-alpha (TNF) in acute myeloid leukemia (AML) blasts.
Sissolak G; Hoffbrand AV; Mehta AB; Ganeshaguru K
Leukemia; 1992 Nov; 6(11):1155-60. PubMed ID: 1434798
[TBL] [Abstract][Full Text] [Related]
35. Expression of CD86 in acute myelogenous leukemia is a marker of dendritic/monocytic lineage.
Re F; Arpinati M; Testoni N; Ricci P; Terragna C; Preda P; Ruggeri D; Senese B; Chirumbolo G; Martelli V; Urbini B; Baccarani M; Tura S; Rondelli D
Exp Hematol; 2002 Feb; 30(2):126-34. PubMed ID: 11823047
[TBL] [Abstract][Full Text] [Related]
36. Leukemia blast-induced T-cell anergy demonstrated by leukemia-derived dendritic cells in acute myelogenous leukemia.
Narita M; Takahashi M; Liu A; Nikkuni K; Furukawa T; Toba K; Koyama S; Takai K; Sanada M; Aizawa Y
Exp Hematol; 2001 Jun; 29(6):709-19. PubMed ID: 11378266
[TBL] [Abstract][Full Text] [Related]
37. Interferon-alpha disables dendritic cell precursors: dendritic cells derived from interferon-alpha-treated monocytes are defective in maturation and T-cell stimulation.
Dauer M; Pohl K; Obermaier B; Meskendahl T; Röbe J; Schnurr M; Endres S; Eigler A
Immunology; 2003 Sep; 110(1):38-47. PubMed ID: 12941139
[TBL] [Abstract][Full Text] [Related]
38. Induction of leukemia-specific cytotoxic response by cross-presentation of late-apoptotic leukemic blasts by autologous dendritic cells of nonleukemic origin.
Spisek R; Chevallier P; Morineau N; Milpied N; Avet-Loiseau H; Harousseau JL; Meflah K; Gregoire M
Cancer Res; 2002 May; 62(10):2861-8. PubMed ID: 12019165
[TBL] [Abstract][Full Text] [Related]
39. Effect of interleukin-1, tumor necrosis factor-alpha, and interferon-alpha on the blast cells of acute myeloblastic leukemia.
Carter A; Silvian-Draxler I; Tatarsky I
Am J Hematol; 1992 Aug; 40(4):245-51. PubMed ID: 1503080
[TBL] [Abstract][Full Text] [Related]
40. [Induction of efficient T-cell immunity against autologous leukemia cells by dendritic cells pulsed with the leukemia cell total RNA].
Ge W; You SG; Wang YF; Li CH; Liu XF; He XP; Ma S; Qiu L
Zhonghua Xue Ye Xue Za Zhi; 2005 Aug; 26(8):461-4. PubMed ID: 16383235
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]